John Maraganore

Latest articles

4d
Business Wire
Vir Biotechnology Builds Pipeline, Capabilities, and Lays Out Strategy to Address Serious Infectious Diseasesthe company’s CMV-based HIV and tuberculosis vaccine programs, is expected to p
Business Wire / Posted 4 days ago
the company’s CMV-based HIV and tuberculosis vaccine programs, is expected to provide funding to execute these programs. John Maraganore, Chief Executive Officer of Alnylam, commented: “Vir represents a unique opportunity for us to partner... Read more
4d
Business Wire
Alnylam and Vir Form Strategic Alliance to Advance RNAi Therapeutics for Infectious Diseasesthese medicines, while enabling Alnylam to maintain operational focus on our ro
Business Wire / Posted 4 days ago
these medicines, while enabling Alnylam to maintain operational focus on our robust pipeline of later-stage programs,” said John Maraganore, Ph.D., Chief Executive Officer of Alnylam. "We believe the innovative structure of this deal, including the... Read more
12d
Boston Globe
Alnylam poised to roll out first-of-its-kind RNA therapy, with a lot riding on the drugmarket capitalization now exceeds $11 billion. “Alnylam’s results came out wit
Boston Globe / Posted 12 days ago
market capitalization now exceeds $11 billion. “Alnylam’s results came out with a bang, not a whimper,” said Alnylam CEO John Maraganore. “It highlights the fact that these medicines can really be transformative, turning off production of genetic... Read more

In this news